Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Tendances et résultats de la greffe de cellules souches hématopoïétiques (GCSH) dans la thalassémie au sein de l’EBMT

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Trend and outcome of HSCT in Thalassemia inside the EBMT

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella

Impact of AB0 Incompatibility on HSCT outcome in hemoglobinopathies: A Retrospective Registry Study from the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Katharina Kleinschmidt

Outcomes after graft failure of allogeneic hematopoietic stem cell transplantation in patients with SCD

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Josu de la Fuente

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for Acute Myeloid Leukemia in Children- A combined CIBMTR and EBMT analysis

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Patients who undergo a Stem cell Transplant may be at risk of being admitted to the PICU

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Myeloablative conditioning for allo-HSCT in pediatric ALL and AML below 2 years

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

André Willasch

Phase 2 trial to assess haploidentical a/ß T-depleted stem cell transplantation in patients with sickle cell disease with no available sibling donor (T-Haplo-HSCT for SCD)

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Selim Corbacioglu

Allogeneic hematopoietic stem cell transplantation for the BCR-ABL1 negative myeloproliferative neoplasms in children

Retrospective Studies

Myeloproliferative Neoplasm (MPN)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Jacek Wachowiak

Thrombopoietin receptor agonists post HSCT in pediatric patients

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Asaf David Yanir

Haploidentical stem cell transplantation using PTCY for children with acute leukemia

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Annalisa Ruggeri

Use of eculizumab to treat thrombotic microangiopathy associated with haematopoietic stem cell transplantation - a retrospective study on behalf of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal